WADA Independent Observer Report Olympic Games 2000 Sydney, Australia / Harri Syväsalmi. - Independent Observer Team. - World Anti-Doping Agency (WADA), 2000

Contents:

- Introduction
- Laboratory
- Doping Control Command Centre
- Doping Control Stations
- Doping Control Officers
- Doping Control Procedures
- Courier
- Recommendations
- Annex 1. Medical Report
- Annex 2. Laboratory Report
- Annex 3. Result Management
- Appendices:
- IO Terms of Reference
- Confidentiality Document
- Conflict of Interest Doc
- IO Team
- Observation Summary

Rapportage Audit Commissie Doping november 2000 / Segaar, C.A., Dam, J.G. van, Vervoorn, C. . - Arnhem : Audit Commissie Doping, 2000.
- half jaarlijkse rapportage aan de Algemene Vergadering NOC*NSF, het bestuur NOC*NSF, de Staatssecretaris van Volksgezondheid, Welzijn en Sport (VWS) en het bestuur van het Nederlands Centrum voor Dopingvraagstukken (NeCeDo).
- Afhankelijk van de rapportage periode zijn de gegevens over de periode 20-07-2000 tot 30-09-2000 of over de periode 01-01-2000 tot 30-09-2000 genoteerd.

Inhoud:

- Taakstelling audit commissie doping
- Stand van zaken werkzaamheden audit commissie doping
- Verzoek aan bonden met betrekking tot rapportage periode
- Verzoek aan bonden met betrekking tot het aanleveren van uitslagen en sancties
- Beveiliging netwerk
- Toelichting schema rapportage
- Conclusies rapportage november 2000

AUSTRALIAN SPORTS DRUG AGENCY 1999-2000 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Table of contents
Abbreviations vii
1. Australian Sports Drug Agency 1
Purpose 1
Strategic direction 1
Key result areas 1
3. ASDA highlights 2
3. Chairperson's summary 3
4. Corporate governance 6
Constitution 6
Board Members 6
Accountability arrangements 8
Reporting Style 10
Ethical Standards of behaviour 10
Probity Audit 11
Athletes Rights , 11
Regulatory compliance 12
Issues management 12
Corporate structure 13
5. Critical success factors 14
Quality of products and services 14
Communication 30
Ghent focus . 34
Strategic alliances . 27
Accountability 32
Staff partnerships 35
6. Strategic breakthrough issues 40
Enhance the credibility and affordability of our drug testing service 40
Grow the business to achieve a sustainable economic future 43
Invest in our people to build a dynamic, innovative and
client focused organisation 45
Play a leading role in the development of drugs-in-sport policy
in Australia 47
7. Australian Sports Drug Medical Advisory Committee 49
ASDMAC financial report 51
8. Appendices 52
Appendix A — Powers of the Minister under the ASDA Act 52
Appendix B — The objects, functions and powers of the agency
as specified in the ASDA Act 53
Appendix C — Financial statements 55
Appendix D — Drug- testing for 1999-2000 99
Appendix E — Olympic Movement Anti-Doping Code 107
Appendix F — Laboratories for doping control analyses accredited
by the International Olympic Committee 112
Appendix G — Register of Notifiable Events 120
Appendix H — International List of Incidences 124
Appendix I — International anti-doping and drug testing agreements 125
Tables
Table 1 — Relationship between old program structure and
the new outcome structure 9
Table 2 — Strategic planning/outputs matrix 10
Table 3 — Quality of products and services performance indicators 14
Table 4 — Communication performance indicators 20
Table 5 — Client focus performance indicators 24
Table 6 — Strategic alliance performance indicators 28
Table 7 — Accountability performance indicators 32
Table 8 — Staff partnership performance indicators 35
Table 9 — Enhance the credibility and affordability of our
drug testing service milestones _ 40
Table 10 — Grow the business milestones 43
Table 11 — Invest in our people to build a dynamic, innovative and
client focused organisation milestones 45
Table 12 — Play a leading role in the development of drugs-in-sport
policy in Australia 47
Figure 1 — ASDA corporate structure 13
Figure 2 — Drugs in Sport Handbook, Wallet Card and Drugs in
Sport Hotline comparative for 199S-1999 to 1999-2000 21
Figure 3 — External client satisfaction 25
Figure 4 — Staffing numbers, classifications and genders 37
Figure 5 — Staffing employment breakdown 38

AUSTRALIAN SPORTS DRUG AGENCY 1997-1998 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

TABLE OF CONTENTS
Figures iii
Tables iii
Abbreviations iv
Part 1: Executive Summary 1
Chairman's summary 1
Board of directors 3
Part 2: Organisational Overview 5
ASDA at a glance 5
Establishment 5
Role 5
Clients 5
Services 6
Goals 6
People 6
Financial and staffing outcomes for 1997-98 8
Part 3: Performance Report 9
Planning and Performance Management Framework 9
Introduction 9
Enabling strategies and performance drivers 9
Reporting style 10
Critical success factors 11
Communication 20
Client focus 25
Strategic alliances 29
Accountability 33
Staff partnerships 37
Strategic breakthrough issues 41
Enhance the credibility and affordability of our drug testing service 41
Grow the business to achieve a sustainable economic future 45
Invest in our people to build a dynamic, innovative and client focused organisation 48
Play a leading role in the development of drugs-in-sport policy in Australia 52
Part 4: Other Corporate Matters 57
Miscellaneous statutory issues 57
Client Service Charter 57
Internal and external scrutiny 57
Equal employment opportunity 57
Occupational health and safety 58
Industrial democracy 59
Discretionary grants 60
Freedom of information 60
Staffing overview 60
Compliance index 61
Part 5: Appendices 63
Appendix A 63
The objects, functions and powers of the agency as specified in the ASDA Act 63
Appendix B 65
Powers of the Minister under the ASDA Act 65
Appendix C 66
Financial statements 66
Appendix D 85
International List of Incidences 85
Appendix E 87
ASDA's drug testing for 1997-98 87
Government-funded testing 1997-98 88
User-pays testing 1997-98 89
Appendix F 90
Register of Notifiable Events 90
Entries on Register of Notifiable Events from previous years where outcomes were to be advised 92
Appendix G 93
Laboratories for doping control analyses accredited by the International Olympic Committee 93

Figures
Figure 1: ASDA's organisational structure 7
Figure 2: Athletes perceive deterrent effect from ASDA programs 13
Figure 3: Athletes believe they will be tested in next 12 months 14
Figure 4: Tests conducted versus tests planned per bimonthly plan 15
Figure 5: Annual trends in event and out-of-competition testing 16
Figure 6: Client's perception of ASDA resources and educational services 22
Figure 7: Hotline education services trends from 1991-92 to 1997-98 23
Figure 8: External client satisfaction with ASDA services 26
Figure 9: Internal client service indicators for period December 1997 to May 1998 27
Figure 10: Annual event testing agreements with international clients 31
Figure 11: Corporate costs per ASL 34
Figure 12: Organisational Self Assessment - all categories: management and staff. 35
Figure 13: Staff Satisfaction Survey 1997-98 - whole organisation 39
Figure 14: ASDA's quality approach 49
Figure 15: EEO issues from 1997-98 Staff Satisfaction Survey 58
Figure 16: Staffing numbers, classifications and genders 61
Figure 17: Staffing employment breakdown 61

Tables
Table 1: Expenditure and staffing 8
Table 2: Quality of products and services performance indicators 12
Table 3: Athlete perception of banned doping practices as cheating 18
Table 4: Communication performance indicators 21
Table 5: Client focus performance indicators 25
Table 6: Strategic alliance performance indicators 30
Table 7: Accountability performance indicators 33
Table 8: Staff partnership performance indicators 38
Table 9: Enhance the credibility and affordability of our drug testing service milestones 42
Table 10: Grow the business to achieve a sustainable economic future milestones 45
Table 11: Invest in our people to build a dynamic, innovative and client focused organisation 48
Table 12: Training identified for competency development 50
Table 13: Play a leading role in the development of drugs-in-sport policy in Australia 53
Table 14: Extract from Staff Satisfaction Survey 1997-98 59
Table 15: Extract from organisational self assessment report - February 1998 60
Table 16: Compliance index 62

AUSTRALIAN SPORTS DRUG AGENCY 1996-97 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Tabel of contents
The structure of this report iv
Compliance index v
Abbreviations ix
Chairman's Introduction x
Board of Directors xii

Chapter 1
Corporate overview
Legislative basis
Responsible Minister
Our mission and values.
Sharpening our focus 2
Our partners 3
Social justice and equity 4
Discretionary grants 4
Internal and external scrutiny 4

Chapter 2
Critical Success Factor One: Deterence 7
Objective 1
Objective 2
Objective 3
Increase the perceived risk of being selected for a drug test 9
Increase the standard of drug testing and sample collection procedures 17
Increase the comprehensive nature of the response by sports
to banned doping practices 24

Chapter 3
Critical Success Factor Two: Education 29
Objective 4: Increase the perception that banned doping practices are cheating 30
Objective 5: Increase the skills and knowledge of government and
non-government clients 32
Objective 6: Increase the knowledge of athletes and coaches of the international
response to drugs in sport 36
Objective 7: Increase the sporting community's awareness of ASDA activities 37

Chapter 4
Critical Success Factor Three: International Response 39
Objective 8: ncrease the effectiveness of international anti-doping programmes 40
Objective 9: Increase the skills and knowledge of international clients 44

Chapter 5
Critical Success Factor Four: National Response 51
Objective 10: Increase the effectiveness of the national response to the drugs in sport issue 52

Chapter 6
Critical Success Factor Five: Client Participation 55
Objective 11: Increase the effectiveness of client involvement in planning, implementation and evaluation of agency activities 56

Chapter 7
Critical Success Factor Six: Efficiency and Accountability 61
Objective 12: Increase the effectiveness of systems and structures to enable staff to meet their responsibilities 62
Objective 13: Increase the skills of staff to meet agency's requirements 69
Objective 14: Increase the effectiveness of the planning and evaluation process 72

Chapter 8
Financial Statements 75
Independent audit report by the Australian National Audit Office 76
Statement by Directors 78
Operating statement for year ended 30 June 1997 79
Statement of assets and liabilities as at 30 June 1997 80
Statement of cash flows for the year ended 30 June 1997 81
Schedule of commitments for the year ended 30 June 1997 82
Schedule of contingencies for the year ended 30 June 1997 83
Notes to and forming part of the Financial Statements for the year ended 30 June 1997 84

Appendix 1 Objects, functions and powers of the Australian Sports Drug Agency as specified in the Australian Sports Drug Agency Act 1990 92
Appendix 2 Powers of the Minister under the Australian Sports Drug Agency Act 1990 94
Appendix 3 Summary of Entries on Register of Notifiable Events 1996-97 95
Appendix 4 ASDA testing for period 1 July 1996 to 30 June 1997 98
Appendix 5 ASDA user-pays testing for period 1 July 1996 to 30 June 1997 101
Appendix 6 Outcome of previous entries on Register of Notifiable Events for which sanctions were to be advised 103
Appendix 7 Summary of entries on Register of Notifiable Events by doping class and sport 1996-97 104
Appendix 8 Summary of entries on the Register of Notifiable Events 1991-92 to 1996-97 105
Appendix 9 Summary of entries on the International List of Incidences 1996-97 106
Appendix 10 Outcome of previous entries on the International List of Incidences for which sanctions were to be advised 106
Appendix 11 International Olympic Committee Medical Code - Prohibited classes of substances and prohibited methods 107
Appendix 12 Implementation of the National Drugs in Sport Framework by states and territories; policy, educational, legislative and drug testing components 113
Index 115

Figures
Figure 1.1 Australian Sports Drug Agency structure at 30 June 1997 2
Figure 2.1 Drug testing conducted 1992-93 to 1996-97 11
Figure 3.1 Comparison of hotline usage 33
Figure 3.2 Analysis of hotline queries 34
Figure 3.3 Handbook, hotline and Infopac distribution 35

Tables
Table 1.1 ASDA expenditure by programme 3
Table 1.2 ASDA financial and staffing resources summary 5
Table 6.1 Total number of employees at 30 June 1997 59

AUSTRALIAN SPORTS DRUG AGENCY 1995-96 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

Abbreviations and acronyms viii
Executive summary ix

Chapter 1
introduction 1
Responsible Minister 2
Membership 2
Social justice and equity 4
Internal and external scrutiny 5

Chapter 2
Testing, Research and Policy 7
Objectives and resources 7
Drug testing 7
inter-governmental agreements 13
Register of Notifiable Events 13
Drug testing officials 15
Advice to sporting organisations 16
Legislation 18
Analytical services 20
Special interest groups 21
Special operational issues 23

Chapter 3
Education 27
Objectives and resources 27
National Drugs in Sport Framework 27
Sport-based education programs 28
School-based education programs 34
Information services 37
Public relations 41

Chapter 4
International 45
Objectives and resources 45
International anti-doping agreements 45
International anti-doping policies and programs 49
Provision of information and advice 51

Chapter 5
Corporate 53
Objectives and resources 53
Planning and evaluation 53
Research 54
Financial management 56
Human resource management 57
Social justice 60
Administrative services 62

Chapter 6
Financial statements 65

Appendices
1 Objects, functions and powers of the Australian Sports Drug Agency as specified in the Australian Sports Drug Agency Act 1990 82
2 Powers of the Minister under the Australian Sports Drug Agency Act 1990 84
3 Presentations by ASDA officials 1995-96 86
4 Doping control laboratories accredited by the International Olympic Committee 88
5 International Olympic Committee Medical Code 92
6 ASDA testing for period 1 July 1995 to 30 June 1996 98
7 ASDA user-pays testing for period 1 July 1995 to 30 June 1996 100
8 Summary of entries on Register of Notifiable Events 1995-96 101
9 Outcome of 1994-95 entries on Register of Notifiable Events for which sanctions were to be advised 103
10 1995-96 Memorandum of Agreement between the Australian Sports Drug Testing Laboratory and the Australian Sports Drug Agency 104
11 State Coordinators of the School Development in Health Education Project 109
12 Educational resource material distribution 1995-96 110
13 Sport Drug Education Unit advisory committees 1995-96 111
14 The International Anti-Doping Arrangement 112
15 International drug testing statistics 1994 115
16 International clients 1995-96 117
17 Summary of compliance with reporting guidelines 118
Index 119

Tables
1.1 Primary functions of each program area 1
1.2 ASDA financial and staffing resources summary 5
1.3 ASDA expenditure by program 5
2.1 Summary of entries on Register of Notifiable 14
Events by doping class and sport 1995-96
2.2 Summary of entries on the Register of Notifiable 15
Events 1991-92 to 1995-96
3.1 Drugs in Sport Hotline summary 1995-96 40
5.1 Total-number of employees at 30 June 1996 59
5.2 Summary of training undertaken 60
5.3 Categories of training 60
Figures
1.1 Organisation of ASDA 4
3.1 Drugs in Sport Handbook and Wallet Card distribution 1995-96 37
3.2 Hotline statistics 1995-96 39

Robert D. Kersey, PhD, ATC, CSCS
San Jose State University in San Jose, CA 95192-0054.
Journal of Athletic Training - Volume 31 * Number 3 * September 1996

Objective: To determine the incidence of anabolicandrogenic
steroid use among a sample of community college
student-athletes; also, to compare various aspects of users and
nonusers, as well as to describe usage patterns.

Design and Setting: A survey following random stratified
cluster sampling techniques was administered to 10 California
community colleges.

Subjects: A group of 1,185 male and female studentathletes.
Measurements: An anonymous 27-item, valid, and reliable
questionnaire was administered surveying anabolic-androgenic
steroid use and usage patterns.

Results: Of all student-athletes sampled, 3.3% were anabolic-
androgenic steroid users. Gender-specific incidence rates
were 4.2% for males and 1.2% for females. Anabolicandrogenic
steroid users tended to be older males, usually intheir second year of college. The users were more often
minorities. Users believed that they were knowledgeable about
anabolic-androgenic steroids, and that the rates of usage were
higher than reported. Their sources of steroid information were
often lifting partners and fellow athletes. Use of these drugs
was most often in cycles (mean of 6.7 weeks) and was
frequently done using multiple anabolic-androgenic steroids at
a time. The average number of cycles completed was 2.9. A
wide variety of steroids were used by the student-athletes, of
which most were obtained from illegal sources.

Conclusions: Anabolic-androgenic steroid use among California
community college student-athletes were similar to other
previous research studies involving high school and university
student-athletes.

Key Words: anabolic steroid(s), athlete, ergogenic aid(s)

AUSTRALIAN SPORTS DRUG AGENCY 1994-95 ANNUAL REPORT
© Commonwealth of Australia
ISSN 1037-378

TABLE OF CONTENTS

Chapter 1
Introduction 1
Responsible Minister 3
Membership 3
Organisational structure 5
Presentations 6
Social justice 6
internal and external scrutiny 6

Chapter 2
Testing, research and policy 9
Objectives and resources 9
Drug testing 9
Register of Notifiable Events 14
Drug testing officials 15
Analytical services 16
Research 18
Policy 19
International Court of Arbitration for Sport 21
Special interest groups 21
Legislation 24
Special operational issues 26

Chapter 3
Education 29
Objectives and resources 30
School-based education programs 30
Sport-based education programs 31
information services 35
Public relations 37

Chapter 4
International 41
Objectives and resources 41
Working with international sporting federations 42
International agreements 43
International visitors 46
Drug tests statistical survey 47
Information dissemination 48
Working with government agencies 48

Chapter 5
Corporate 49
Objectives and resources 49
Planning and evaluation 49
Research 53
National activities 54
Finance 56
Human resource management 58
Staff development 59
Social justice 60
Administrative services 64

Chapter 6
Financial statements 67
1 Objects, functions and powers of the Australian Sports Drug Agency as specified in the Australian Sports Drug Agency Act 1990 84
2 Powers of the Minister under the Australian Sports Drug Agency Act 1990 86
3 Presentations by ASDA officials 1994-95 88
4 Doping control laboratories accredited by the International Olympic Committee 90
5 International Olympic Committee Medical Code 100
6 ASDA testing for period 1 July 1994 to 30 June 1995 100
7 User pays testing 1 July 1994 to 30 June 1995 101
8 Summary of Entries on Register of Notifiable Events 1994-95 102
9 1994-95 Memorandum of Understanding between the Australian Government Analytical Laboratories and the Australian Sports Drug Agency 104
10 State Coordinators of the School Development in Health Education Project 107
11 Educational resource material distribution 1994-95 108
12 Sports Drug Education Unit advisory committees 109
13 Portfolio evaluation steering committee 110
14 Memorandum of Understanding between the Australian Sports Drug Agency and the Chinese Olympic Committee Anti-Doping Commission 111
15 International testing statistics 1993 113
16 Agency resources to international clients 1994-95 116
17 Complementary Drug Testing Legislation definition of competitor 118
18 Summary of compliance with reporting guidelines 119
INDEX 120
TABLES
1.1 Financial and staffing resources summary 6
1.2 Expenditure by program 7
2.1 Summary of entries on Register of Notifiable Events by doping class and sport 15
2.2 Summary of defaulting competitors on the Register of Notifiable Events: 1991-92 to 1994-95 15
3.1 Drugs in Sport Hotline — summary 37
5.1 Strategic Plan performance information 51
5.2 Total number of employees at 30 June 1995 59
5.3 Summary of training undertaken 59
5.4 Categories of training 60

Figures
1.1 Mission, vision and corporate values of the Strategic Plan 1995-97 1
1.2 Outcome Hierachy 2
1.3 Primary functions of each program area 3
1.4 Organisation of the Australian Sports Drug Agency 5